Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

October 23, 2009

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

October 21, 2009

Green tea may combat depression in elderly
Drinking frequent cups of green tea a day is linked to a lower incidence of depressive symptoms in elderly people, say Japanese researchers.
Read article at nutraingredients.com

October 19, 2009

Vitamin D may help reduce type 2 diabetes risk
A new study published in the Sept 200 9 issue of British Journal of Nutrition suggests that taking vitamin D supplements may help prevent type 2 diabetes. The small trial shows that taking 4,000 IU of vitamin D3 daily for six months significantly improved insulin sensitivity and insulin resistance in South Asian women.
Read article at foodconsumer.org

October 16, 2009

Omega-3 may protect healthy men from chest pains
Increased intakes of omega-3 fatty acids EPA, DPA, and DHA may protect men against acute coronary syndrome (ACS), says a new study.
Read article at nutraingredients.com

For more natural health news, click here.

See also our 2001-2008 news archive, by clicking here.

Pharma "Business with Disease" News

October 21, 2009

No Surprise Here: Pharma’s DC Lobbying Is Up
With the battle over health care reform still under way, the industry’s trade group spent almost as much on lobbying during the first nine months of this year as in all of 2008, according to records reviewed by Bloomberg News. The Pharmaceutical Research and Manufacturers of America spent $19.9 million to lobby Congress and federal agencies during the first nine months of 2009, according to disclosure statements filed with the U.S. Senate. By contrast, PhRMA spent $20.2 million in all of 2008.
Read article at pharmalot.com

October 21, 2009

Will Novartis Be Found Guilty Of Denying Zometa Risks?
A jury will continue deliberating today a lawsuit brought by a woman who alleges Novartis was negligent when it failed to disclose health risks associated with its Zometa bone-strengthening drug. Peggy Stevens has lymphoma and developed serious dental and jaw-related problems after taking Zometa for several years. Her attorneys say the company knew patients taking the drug were vulnerable to a degenerative jaw disorder called osteonecrosis, particularly those patients who undergo invasive dental procedures, like root canals or tooth extractions, The Missoulian reports. She was given the drug for three years before she had a tooth pulled in 2007 and developed the disease, which can cause pain, loosening of teeth, exposed bone and infection. On a national level, Novartis faces lawsuits from about 550 plaintiffs whose cases have been consolidated in a Tennessee federal court and a New Jersey state court.
Read article at pharmalot.com

October 19, 2009

Putin’s Proposed Reform Worries Drug Producers
MOSCOW — Prime Minister Vladimir Putin has promised to ban pharmaceutical makers from sending representatives to doctors’ offices, a practice they spend up to 50 percent of their revenue on and one of the last open channels for companies to promote prescription drugs. “We should get rid of these so-called pharmaceuticals representatives working in medical institutions,” Putin said Oct. 9 at a meeting on the development of the drugs industry. In the past 10 years, Russia has seen the rise of “a clearly abnormal type of interaction” between medicine producers, particularly foreign companies, and parts of the medical community, he said. It is impermissible to have “pharmaceutical holdings paying specialists to prescribe patients substances produced by these companies,” Putin said.
Read article in The St. Petersburg Times (Russia)

October 19, 2009

Popular Bowel Disease Drugs Linked to Increased Cancer Risks
Imuran, azathioprine, and other drugs which reduce the body’s immune system to treat inflammatory bowel disease can increase the risks of patients developing infection-related cancers, according to a new French study. The drugs belong to a family of medications called thiopurines, which are commonly used to treat a variety of bowel diseases and disorders. Imuran is the brand-name medication made by GlaxoSmithKline, while a handful of generic drug makers produce azathioprine.
Read article at attorneyatlaw.com (USA)

October 16, 2009

2 ALS Cases May Be Linked to Gardasil Vaccine
Researchers Believe Cervical Cancer Vaccine Could Be Linked to Cases of Lou Gehrig's Disease
Researchers believe that there may be a link between a vaccine against cervical cancer and a rapidly progressive, fatal disease in two young women. Both the timing of the symptoms and autopsy results “suggest a link between” the Gardasil vaccine and the fatal cases of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, says Catherine Lomen-Hoerth, MD, director of the ALS Center at University of California San Francisco Medical Center.
Read article at webmd.com

For more pharma "business with disease" news, click here.

See also our 2001-2008 news archive, by clicking here.

GMO News

October 15, 2009

GMO protestors give Brussels food for thought
Greenpeace has taken its objections over genetically modified food to the European Commission’s door in Brussels. The anti-GMO NGO presented the Health Commissioner with a 180,000 signature petition calling for the EU to refuse the authorisation of GM rice made by German chemical giant Bayer.
Read article at euronews.net

For more GMO news, click here.

See also our 2001-2008 news archive, by clicking here.

Other Health-related News

October 20, 2009

No Deaths From Vitamins or Minerals
Poison Control Statistics Prove Supplements' Safety
There was not even one death caused by a vitamin or dietary mineral in 2007, according to the most recent statistics available from the U.S. National Poison Data System. The 132-page annual report of the American Association of Poison Control Centers published in the journal Clinical Toxicology shows zero deaths from multiple vitamins; zero deaths from any of the B vitamins; zero deaths from vitamins A, C, D, or E; and zero deaths from any other vitamin. Furthermore, there were zero deaths in 2007 from any dietary mineral supplement. This means there were no fatalities from calcium, chromium, zinc, colloidal silver, selenium, iron, or multimineral supplements. There was one death from chronic overdose of magnesium hydroxide, commonly known as the laxative/antacid milk of magnesia, and it was inappropriately listed in the "dietary supplement" reporting category. Nutritional supplements do not contain magnesium hydroxide.
Read news release at orthomolecular.org

For more health-related news, click here.

See also our 2001-2008 news archive, by clicking here.

Political News

October 15, 2009

Chilcot inquiry may consider legality of Iraq war
The Chilcot Inquiry into the Iraq war has appointed one of the most renowned experts on international law as an adviser, in what is viewed as an indication that the Blair government's legal justification for the invasion is to come under serious scrutiny.Dame Rosalyn Higgins, who was the most senior female judge in the world when she was the president of the International Court of Justice, will advise the panel on legal issues as well as the wider investigation.
Read article on the Independent (UK)

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website.

Back to the Newsletter Archive…